Trine Lindsted

Trine Lindsted has a diverse work experience spanning from 2007 until the present time. From 2007 to 2013, they worked as a research assistant and later pursued their Ph.D at Cold Spring Harbor Laboratory. Trine then joined Symphogen in 2013 and held various roles within the company. From 2013 to 2015, they served as a Scientist, followed by a promotion to Senior Scientist from 2015 to 2018. Afterwards, they became a Principal Scientist in Cancer Biology and Immunology until 2019. Trine then assumed the position of Team Manager for Target Biology and Assays, a role they held until 2022 when they were promoted to their current position as Director of Target Biology and Assays at Symphogen.

Trine Lindsted's education history begins in 2002 when they started their studies at Aarhus University. Trine pursued a Master's degree in Health Sciences and graduated in 2007. Continuing their academic journey, Trine Lindsted then enrolled at the same university and began their Ph.D. in Medicine in 2008, which they completed in 2013. No specific field of study is mentioned for their Ph.D. In an unspecified time frame, Trine Lindsted also had an academic affiliation with Cold Spring Harbor Laboratory, but no degree or field of study is indicated for this experience.